East China medicine: the subsidiary ornidazole tablets passed the conformity evaluation of generic drugs
Financial Associated Press, September 29 - East China medicine announced that the ornidazole tablets produced by the company's wholly-owned subsidiary East China Medicine (Xi'an) Bohua Pharmaceutical Co., Ltd. passed the consistency evaluation of generic drug quality and efficacy. Ornidazole is used to treat a variety of diseases caused by anaerobic infection, such as Trichomonas urogenital tract infection in men and women, Giardia flagellate infection and so on.
This text is a result of machine translation.
Related companies：
In-depth
Technology
Successful Multinational Corporations in China Series: Qualcomm China
Since China's reform and opening-up, many multinational corporations and groups have achieved success in China. They have not only been successful in their fields, but some also benefitted from wise M&A moves or investments. To answer these questions EqualOcean launches its Successful Multinational Corporations in China and analyzes the critical points of investing in China for investors and people interested in such a topic.
Updated 1 hour ago
May 02, 2022 07:50 PM
Apr 18, 2022 09:14 PM
Apr 18, 2022 06:30 PM
Apr 11, 2022 08:42 PM
Sunshine City responded to the rumor that the interest extension plan was approved: the news is true
Briefing Jan 18, 2022 01:49 PM
· Technology
The trading amount of well-off shares was nearly 1.5 billion
See more
Read next
In-depth
In-depth
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.